biotx.ai GmbH
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Phase II Safety Single-arm Study of CDK4/6 Inhibition With Palbociclib in Hospitalized, Moderate COVID-19 Cases to Prevent Thromboinflammation (NCT05371275) | biotx.ai GmbH | 2022-04-21 |
Track biotx.ai GmbH automatically
Every clearance here is in the API, with alerts when new ones post.